IL13 and Alzheimer disease: Therefore, our overall aim was to develop a comprehensive transcriptomic understanding of three Th2 diseases (EoE, AD, and AA) across three different model systems: inflamed tissues from patients with EoE, AD, or AA; primary epithelial cells stimulated with IL-13 in vitro; and tissues from murine models of each disease.